Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

This study has been withdrawn prior to enrollment.
(PI left Institution)
Sponsor:
Information provided by:
Roger Williams Medical Center
ClinicalTrials.gov Identifier:
NCT00022230
First received: August 10, 2001
Last updated: August 9, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)